WHO (World Health Organization) Target Product Profile for Lassa Virus Vaccine

World Health Organization. 06/2017 This 11-page document is a vaccine target product profile that followed prioritization of Lassa fever as part of the World Health Organization (WHO) R&D Blueprint for Action to Prevent Epidemics. The criteria lay out some of the considerations that will be relevant in WHO ' s case-by-case assessments of Lassa virus vaccines in the future. The profile considers two scenarios: non-emergency setting (preventive use), and emergency setting (reactive/outbreak use). (PDF)

Source: Disaster Lit: Resource Guide for Disaster Medicine and Public Health - June 30, 2017 Category: International Medicine & Public Health Authors: The U.S. National Library of Medicine Source Type: news